Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer
Michael Clemens, Oleg Gladkov, Elaina M. Gartner, Vladimir Vladimirov, John Crown, Joyce Steinberg, Fei Jie, Anne Keating
Breast Cancer Research and Treatment, 2014
Abstract
This research paper explore the methodology and findings associated with Breast Cancer Research and Treatment. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).